How AI is Changing the Game for Self-Directed Investors
I just got back from a road trip around Iceland — and with 23 hours of daylight, I barely slept. I had a ton of time in the car, so…
I just got back from a road trip around Iceland — and with 23 hours of daylight, I barely slept. I had a ton of time in the car, so…
Quarterly payers are the norm. But monthly dividends…. Yeah, that’s that stuff. Today we’ll chat about five monthly divvies that yield between 5.8% and 16.3% per year. That’s right, these…
You don’t bring me flowers You don’t sing me love songs You hardly talk to me anymore When you come through the door At the end of the day –…
Investing used to be something reserved for a privileged few. If we go back even just 20 years ago, brokerages were difficult and expensive to access, and research was very…
Dividends can provide you with stable income through all market environments. Today, the broad market S&P 500 index has a tiny dividend yield of 1.2%, which is significantly less than…
The One Big Beautiful Bill Act (BBB) is now law—and there’s one contrarian move we can make now to profit from it. I’m not talking about shorting 10-year Treasuries (though…
Are dividend stocks only for investors nearing or in retirement? Not at all. Consider that more than half of the S&P 500’s (^GSPC) total return over the last 50 years…
The last bargains on the big board? Discounted closed-end funds (CEFs). CEFs are often the “last stop” for dividend deals. We are talking about an inefficient corner of the income…
I keep hearing about the widening wealth divide in the US. As someone who grew up in abject poverty but now enjoys the benefits of wealth, I find this to…
There are different ways to use dividends when it comes to selecting investments. Often, dividend investors focus all their attention on the highest-yielding stocks. But you can also buy stocks…
Maybe you’ve heard some variation on this fear in the last few years: A lot of American companies are going to default on their debts. I know I have. Frankly,…
In 2013, AbbVie (ABBV) became a publicly traded corporation after splitting from its former parent company, Abbott Laboratories (ABT). Since then, both have produced strong returns and have been great…